An approach to use of an adaptive procedure to clinical trials for molecularly heterogenous subject selection at interim

DOI10.1080/03610926.2018.1543770OpenAlexW2902329286MaRDI QIDQ5085585FDOQ5085585

Authors: Feng-shou Ko 

Publication date: 27 June 2022

Published in: Communications in Statistics: Theory and Methods (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1080/03610926.2018.1543770

zbMATH Keywords

clinical trialsheterogeneitygenomic biomarkersample size re-estimationphase III trial

Mathematics Subject Classification ID

Statistics (62-XX)

Cites Work

• A sample size adjustment procedure for clinical trials based on conditional power
• Evaluate the relative efficiency of a targeted clinical trial design to an untargeted design under the issue of cost
• Discussion on the issue of sample size determination for a targeted to an untargeted and to a mixed effect model-based clinical trial design

This page was built for publication: An approach to use of an adaptive procedure to clinical trials for molecularly heterogenous subject selection at interim

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5085585)